Aquapharm's discovery platform starts with the isolation of micro-organisms collected from diverse and extreme marine habitats and the generation of chemical extracts.
Aquapharm's microbial database contains information on their source location, culture conditions, chemistry and activity profile which allows for the efficient targeting of the most productive microbes for a particular biological activity. The Company's screening activities focus on the identification of new products in the therapeutic areas of:
- infectious disease
- inflammation and
- oxidative stress
The Company's discovery process combines microbiology, screening and natural products chemistry to provide a robust platform for the discovery of novel compounds.